Cargando…

Health economic evaluations comparing faecal microbiota transplantation with antibiotics for treatment of recurrent Clostridioides difficile infection: a systematic review

BACKGROUND: Faecal microbiota transplantation (FMT) is increasingly being used in the treatment of recurrent Clostridioides difficile infection (rCDI). Health economic evaluations may support decision-making regarding the implementation of FMT in clinical practice. Previous reviews have highlighted...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hammeken, Lianna Hede, Baunwall, Simon Mark Dahl, Hvas, Christian Lodberg, Ehlers, Lars Holger
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7805077/ https://www.ncbi.nlm.nih.gov/pubmed/33439367 http://dx.doi.org/10.1186/s13561-021-00301-7

Ejemplares similares

Health-related quality of life in patients with recurrent Clostridioides difficile infections
por: Hammeken, Lianna H., et al.
Publicado: (2022)

Faecal microbiota transplantation for recurrent Clostridioides difficile infection: An updated systematic review and meta-analysis
por: Baunwall, Simon Mark Dahl, et al.
Publicado: (2020)

Early Economic Assessment of Faecal Microbiota Transplantation for Patients with Urinary Tract Infections Caused by Multidrug-Resistant Organisms
por: Baek, Olivia Dybro, et al.
Publicado: (2023)

Gut microbiota differs between treatment outcomes early after fecal microbiota transplantation against recurrent Clostridioides difficile infection
por: Wei, Shaodong, et al.
Publicado: (2022)

Faecal microbiota transplantation: A life-saving therapy challenged by commercial claims for exclusivity
por: Hvas, Christian Lodberg, et al.
Publicado: (2020)

Economic evaluation of Faecal microbiota transplantation compared to antibiotics for the treatment of recurrent Clostridioides difficile infection
por: Abdali, Zainab I, et al.
Publicado: (2020)

Systematic review with meta-analysis: encapsulated faecal microbiota transplantation – evidence for clinical efficacy
por: Cold, Frederik, et al.
Publicado: (2021)

Deep hyperammonemic hepatic encephalopathy precipitated by fecal microbiota transplantation for fulminant Clostridioides difficile infection
por: Eriksen, Lotte Lindgreen, et al.
Publicado: (2021)

Banking feces: a new frontier for public blood banks?
por: Jørgensen, Simon Mark Dahl, et al.
Publicado: (2019)

Cost savings following faecal microbiota transplantation for recurrent Clostridium difficile infection
por: Dehlholm-Lambertsen, Emilie, et al.
Publicado: (2019)

Frailty level at discharge predicts mortality in older patients with Clostridioides difficile more accurately than age or disease severity
por: Rubak, Tone, et al.
Publicado: (2023)

Implementing patient-reported outcomes in clinical decision-making within knee and hip osteoarthritis: an explorative review
por: Sørensen, Natasha Lee, et al.
Publicado: (2019)

The role of faecal microbiota transplantation: looking beyond Clostridioides difficile infection
por: D. Goldenberg, Simon, et al.
Publicado: (2021)

Faecal microbiota transplantation as a home therapy to frail older people
por: Jørgensen, Simon Mark Dahl, et al.
Publicado: (2020)

Faecal Microbiota Transplantation Eradicated Extended-Spectrum Beta-Lactamase-Producing Klebsiella pneumoniae from a Renal Transplant Recipient with Recurrent Urinary Tract Infections
por: Grosen, Anne Karmisholt, et al.
Publicado: (2019)

The Regulatory Approach for Faecal Microbiota Transplantation as Treatment for Clostridioides difficile Infection in Italy
por: de Stefano, Maria Chiara, et al.
Publicado: (2022)

Microbial bile salt hydrolases mediate the efficacy of faecal microbiota transplant in the treatment of recurrent Clostridioides difficile infection
por: Mullish, Benjamin H, et al.
Publicado: (2019)

Characteristics of Faecal Microbiota in Korean Patients with Clostridioides difficile-associated Diarrhea
por: Jeon, Yong Duk, et al.
Publicado: (2019)

The Efficacy of Faecal Microbiota Transplant and Rectal Bacteriotherapy in Patients with Recurrent Clostridioides difficile Infection: A Retrospective Cohort Study
por: Svensson, Camilla Kara, et al.
Publicado: (2022)

Determining Gut Microbial Dysbiosis: a Review of Applied Indexes for Assessment of Intestinal Microbiota Imbalances
por: Wei, Shaodong, et al.
Publicado: (2021)

Changes in microbiota composition, bile and fatty acid metabolism, in successful faecal microbiota transplantation for Clostridioides difficile infection
por: Brown, Jillian R.-M., et al.
Publicado: (2018)

Fecal microbiota transplantation for recurrent Clostridioides difficile, safety, and pitfalls
por: Sandhu, Avnish, et al.
Publicado: (2021)

Faecal microbiota transplantation in Clostridioides difficile infection: real-life experience from an academic Italian hospital
por: Barberio, Brigida, et al.
Publicado: (2020)

Faecal microbiota transplantation for Clostridioides difficile infection: Four years’ experience of the Netherlands Donor Feces Bank
por: Terveer, Elisabeth M, et al.
Publicado: (2020)

Faecal microbiota transplantation as a non-standard therapy for the treatment of Clostridioides difficile in an ulcerative colitis patient
por: Pendrasik, Karolina, et al.
Publicado: (2022)

2432. Durability Against Antibiotics After Response to Fecal Microbiota Transplantation in Recurrent Clostridioides difficile Infection
por: Saha, Srishti, et al.
Publicado: (2019)

Immunological mechanisms of fecal microbiota transplantation in recurrent Clostridioides difficile infection
por: Soveral, Lucas F, et al.
Publicado: (2022)

Short- and long-term follow-up after fecal microbiota transplantation as treatment for recurrent Clostridioides difficile infection in patients with inflammatory bowel disease
por: van Lingen, Emilie (E.), et al.
Publicado: (2023)

Microbiota in Clostridioides difficile-Associated Diarrhea: Comparison in Recurrent and Non-Recurrent Infections
por: Gazzola, Alessandra, et al.
Publicado: (2020)

Faecalibacterium prausnitzii increases following fecal microbiota transplantation in recurrent Clostridioides difficile infection
por: Björkqvist, Olle, et al.
Publicado: (2021)

Heterogeneity of Randomized Controlled Trials of Fecal Microbiota Transplantation in Recurrent Clostridioides difficile Infection
por: Feuerstadt, Paul, et al.
Publicado: (2021)

Hypophosphatemia in a Specialized Intestinal Failure Unit: An Observational Cohort Study
por: Eriksen, Marcel Kjærsgaard, et al.
Publicado: (2020)

Fecal microbiota transplantation beyond Clostridioides difficile infections
por: Wortelboer, Koen, et al.
Publicado: (2019)

Fecal Microbiota Transplantation beyond Clostridioides Difficile Infection
por: Moon, Chang Mo, et al.
Publicado: (2021)

Comorbid status and the faecal microbial transplantation failure in treatment of recurrent Clostridioides difficile infection – pilot prospective observational cohort study
por: Kachlíková, M., et al.
Publicado: (2020)

792. Evaluation of Persistent Diarrhea and Recurrence Following Fecal Microbiota Transplantation for Recurrent Clostridioides difficile Infection
por: Boton, Noah, et al.
Publicado: (2020)

The molecular characters and antibiotic resistance of Clostridioides difficile from economic animals in China
por: Zhang, Wen-Zhu, et al.
Publicado: (2020)

Faecal carriage of Clostridioides difficile is low among veterinary healthcare workers in the Netherlands
por: Meijs, Anouk P., et al.
Publicado: (2022)

Results from the first English stool bank using faecal microbiota transplant as a medicinal product for the treatment of Clostridioides difficile infection
por: McCune, V.L., et al.
Publicado: (2020)

The use of Faecal Microbiota Transplantation (FMT) in Europe: A Europe-wide survey
por: Baunwall, Simon Mark Dahl, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_navbc25b5fc9bo80orps0ncdl3